Venlafaxine and cardiovascular toxicity.

@article{Taylor2010VenlafaxineAC,
  title={Venlafaxine and cardiovascular toxicity.},
  author={David Taylor},
  journal={BMJ},
  year={2010},
  volume={340},
  pages={c411}
}
David Taylor chief pharmacist and professor of psychopharmacology, South London and Maudsley NHS Foundation Trust, London SE5 8AZ david.taylor@slam.nhs.uk Competing interests: DT has received grant funding or speaking honorariums from Servier, Eli Lilly, Lundbeck, AstraZeneca, BristolMyers-Squibb, and Sanofi-Synthelabo, some of which manufacture or distribute antidepressants. Provenance and peer review: Commissioned; not externally peer reviewed. Provenance and peer review: Commissioned; not… CONTINUE READING